PORTLAND, Ore.--(BUSINESS WIRE)--Bioject Medical Technologies Inc. (Nasdaq:BJCT), a leading developer of needle-free injection therapy (NFIT) systems, today announced that Mr. Ralph Makar,
For more information, please visit
http://home.businesswire.com/portal/site[...]sId=20080103005962&newsLang=en